RESUMEN
Dysfunction of the extraorbital lacrimal gland (ELG) can lead to loss of vision due to damage to the epithelium of cornea. The broad-spectrum anti-epileptic drug sodium valproate (SV) has numerous side effects. Moringa oleifera (M.oleifera) is widely used as a food and in folk medicine. The effects of orally administered SV and M. oleifera hydroalcoholic leaf extract on rat ELG were investigated in this study by analysing both antioxidant and oxidant parameters. Additionally, boron level and tissue factor (TF) activity were determined. Protein changes were detected by sodium dodecyl sulfate gel electrophoresis (SDS-PAGE). Significantly lower values of glutathione (GSH), superoxide dismutase (SOD), catalase (CAT) and total antioxidant status (TAS) were observed in the SV group compared to the control group. Treatment with Moringa extract significantly increased SOD, CAT and TAS values in the Moringa given SV group (SVM). While no significant differences were observed between the sialic acid values of the groups, lipid peroxidation (LPO), nitric oxide (NO) and total oxidant status (TOS) values were significantly elevated in the SV group compared to the control group. Due to the effect of Moringa extract, LPO, NO and TOS levels were significantly decreased in the SVM group compared to the SV group. TF activity was not meaningfully altered between groups. Compared to control rats, oxidative stress index (OSI) level significantly increased, whereas the boron level decreased in the SV group. Moringa extract treatment noticeably reduced OSI in the SVM group. According to SDS-PAGE, decreases in the density of protein bands with molecular weights of 51, 83, and 90 kDa were observed in SV given rats compared to the other groups. These decreases were reversed by the administration of Moringa extract. Moringa extract has shown protective properties arising from antioxidant potential, especially with its very low OSI value. Individuals undergoing SV treatment and having ELG complications might consider using Moringa extract to mitigate valproate induced damage.
Asunto(s)
Antioxidantes , Peroxidación de Lípido , Moringa oleifera , Estrés Oxidativo , Extractos Vegetales , Hojas de la Planta , Ratas Wistar , Ácido Valproico , Animales , Moringa oleifera/química , Ratas , Extractos Vegetales/farmacología , Estrés Oxidativo/efectos de los fármacos , Hojas de la Planta/química , Ácido Valproico/farmacología , Ácido Valproico/toxicidad , Antioxidantes/farmacología , Peroxidación de Lípido/efectos de los fármacos , Modelos Animales de Enfermedad , Masculino , Aparato Lagrimal/metabolismo , Aparato Lagrimal/efectos de los fármacos , Anticonvulsivantes/farmacología , Catalasa/metabolismo , Superóxido Dismutasa/metabolismo , Glutatión/metabolismo , Enfermedades del Aparato Lagrimal/metabolismo , Enfermedades del Aparato Lagrimal/tratamiento farmacológico , Enfermedades del Aparato Lagrimal/inducido químicamente , Enfermedades del Aparato Lagrimal/prevención & control , Electroforesis en Gel de Poliacrilamida , Óxido Nítrico/metabolismoRESUMEN
Lacrimal gland adenoid cystic carcinoma (ACC) is associated with high recurrence and mortality rates. Many recent studies have focused on the clinical features of the disease, and a better understanding of its underlying molecular mechanisms may help guide future treatment strategies. For proteomics quantitation, we analyzed normal tissues, benign tumor tissues and ACC tissues by LC-MS/MS with Tandem mass tags (TMTs) labeling. Bioinformatics analysis of the KEGG pathway found that, compared with normal tissues, the expression levels of major proteins related to cell metabolism were lower in benign tumors and cancer tissues of the lacrimal gland. In addition, we also performed IHC staining to verify the expression of representative proteins in tissue samples. All of these results indicated that compared with normal tissues, lacrimal gland tumors had unique metabolic reprogramming characteristics. Further Short Time-series Expression Miner (STEM) analysis revealed that glycine, serine and threonine metabolism in ACC tissues was significantly enhanced compared with that in normal tissues and benign tumor tissues. This finding suggested that glycine, serine and threonine metabolism might be the key to the malignant transformation of ACC; thus, assessing the metabolism in these tissues could be an effective approach enabling the early diagnosis of ACC, and the proteins involved in these metabolic pathways could represent therapeutic targets.
Asunto(s)
Neoplasias del Ojo , Enfermedades del Aparato Lagrimal , Aparato Lagrimal , Cromatografía Liquida , Neoplasias del Ojo/metabolismo , Glicina/metabolismo , Humanos , Aparato Lagrimal/metabolismo , Enfermedades del Aparato Lagrimal/metabolismo , Proteómica , Serina/metabolismo , Espectrometría de Masas en Tándem , Treonina/metabolismoRESUMEN
PURPOSE: VEGF and HIF-1α are important regulators of angiogenesis, overexpressed in various tumors. Lacrimal gland Adenoid cystic carcinoma (ACC) is a malignant tumor whose angiogenic properties remain unexplored. This study was designed to evaluate the expression of HIF-1α and VEGF in lacrimal gland ACC. METHODS: VEGF and HIF-1α immunoexpression was undertaken in 30 lacrimal gland ACC cases. mRNA expression of VEGF and HIF-1α was analysed in 17 cases by quantitative real time PCR. The results obtained were correlated with clinicopathological features and survival of the patients to determine the prognostic significance. RESULTS: Immunoexpression of HIF-1α and VEGF was seen in 36.6% and 46.6% ACC cases. HIF-1α expression showed significant association with advanced T-stage (P = 0.001) and VEGF with intracranial extension (P = 0.014) and solid histological pattern (P = 0.045). HIF-1α mRNA expression was seen in 29.4% cases and showed significant association with perineural invasion (P = 0.027). Recurrence occurred in 60%, distant metastasis in 20% and death in 20% cases. Survival analysis revealed that patients with HIF-1α, VEGF immunoexpression, solid histological pattern, perineural invasion, bone erosion, intracranial extension, metastasis, advanced T-stage, and exenteration had poor survival. On multivariate analysis VEGF immunoexpression (hazard ratio, 16.785; 95% confidence interval, 1.872-150.495; P = 0.012) was the most significant poor prognostic factor. CONCLUSIONS: This study demonstrates that VEGF is a potential predictor for poor clinical outcome in lacrimal gland Adenoid cystic carcinoma.
Asunto(s)
Biomarcadores de Tumor/metabolismo , Carcinoma Adenoide Quístico/metabolismo , Neoplasias del Ojo/metabolismo , Subunidad alfa del Factor 1 Inducible por Hipoxia/metabolismo , Enfermedades del Aparato Lagrimal/metabolismo , Aparato Lagrimal/metabolismo , Factor A de Crecimiento Endotelial Vascular/metabolismo , Adolescente , Adulto , Anciano , Carcinoma Adenoide Quístico/diagnóstico , Carcinoma Adenoide Quístico/mortalidad , Neoplasias del Ojo/diagnóstico , Neoplasias del Ojo/mortalidad , Femenino , Estudios de Seguimiento , Humanos , Enfermedades del Aparato Lagrimal/diagnóstico , Enfermedades del Aparato Lagrimal/mortalidad , Masculino , Persona de Mediana Edad , Pronóstico , Estudios Retrospectivos , Análisis de Supervivencia , Adulto JovenRESUMEN
Tearing maturates rapidly after birth, and external environmental challenges play a key role in promoting lacrimal functional maturation. However, little is known about the facilitative factors underlying this developmental process or the potential of application of these factors to treat hypofunction of the lacrimal gland. In this study, eye opening and the subsequent ocular surface sensory experience, which is thought to be involved in postnatal maturation of lacrimal function, were investigated. Our results demonstrated that eye opening after birth is essential for the maturation of neonatal tearing. The maturation process of lacrimal function is dependent on the ocular surface sensory experience via transient receptor potential cation channel subfamily member 1 after birth. This study provides, for the first time, important evidence of the sensory experience of the ocular surface in relation to the maturation of functional tear secretion during the postnatal period.
Asunto(s)
Córnea/fisiopatología , Enfermedades del Aparato Lagrimal/etiología , Rotura/etiología , Canales Catiónicos TRPV/fisiología , Animales , Animales Recién Nacidos , Enfermedades del Aparato Lagrimal/metabolismo , Enfermedades del Aparato Lagrimal/patología , Ratones Endogámicos C57BL , Ratones Noqueados , Rotura/metabolismo , Rotura/patologíaRESUMEN
The present investigation was aimed to develop a rabbit model for protecting the rabbit eye from systematically induced precorneal tear film (PTF) damage, evaluation of carboxymethyl pullulan for its protective action against PTF damage and its curative potential. For the same, pullulan was modified by carboxymethylation and structural modification was confirmed by spectral attributes. Further, the carboxymethyl pullulan (CMP) solutions (0.1-2.0%, w/v) were evaluated for their physical properties and its concentration 1.5% (w/v) was found to fit the criterion to prepare an eye solution. The safety and non-toxicity of CMP (1.5%, w/v) eye solution was confirmed by HET-CAM method and rabbit eye irritation test. Further, a systematic rabbit eye model was developed that mimic PTF damage in day to day life. Therefore, three levels of PTF damage were developed equating symptoms of damage due to high temperature (level I) or long term mobile use (level II) or heavy air pollution (level III). Thus, a representative model with benzalkonium chloride (BAC, 0.1% v/v, 0.2% v/v and 0.3% v/v), administered two drops twice a day for two days to develop level I, level II and level III eye damage. The CMP (1.5%, w/v) eye solution possessed a protective potential against level I and II PTF damage. The rabbit eyes remained unharmed and comparable with the normal control during the complete experimental period. Additionally, CMP (1.5%, w/v) eye solution has shown early fast recovery (8 days) from PTF damage induced by instillation of PTF damage agent (BAC). Carboxymethyl pullulan eye protective solution has normalized the tear film stability in rabbit eye model. It is established from the present work that, carboxymethyl pullulan has protective action against precorneal tear film damage and it potentiates the early recovery too.
Asunto(s)
Enfermedades de la Córnea/prevención & control , Síndromes de Ojo Seco/prevención & control , Glucanos/uso terapéutico , Enfermedades del Aparato Lagrimal/prevención & control , Lágrimas/metabolismo , Administración Oftálmica , Animales , Enfermedades de la Córnea/metabolismo , Síndromes de Ojo Seco/metabolismo , Glucanos/química , Enfermedades del Aparato Lagrimal/metabolismo , Soluciones Oftálmicas/uso terapéutico , ConejosRESUMEN
Integrase interactor 1 (INI1) is a tumor suppressor gene that is ubiquitously expressed in all nucleated cells. The loss of INI1 protein activity was first demonstrated in aggressive pediatric tumors, including atypical teratoid/rhabdoid (AT/RT) tumor of the central nervous system and malignant rhabdoid tumor of the kidney. Subsequently, INI1 deficiency was discovered in other pediatric and some adult neoplasms. The spectrum of INI1-negative tumors includes a wide variety of neoplasms that occur over a wide age range, are variably aggressive, and have a variable rhabdoid component on histopathologic evaluation. In this report, the authors describe a 27-year-old gravid woman with INI1-deficient carcinoma of the lacrimal gland, previously not described in this location.
Asunto(s)
Enfermedades del Aparato Lagrimal/diagnóstico , Aparato Lagrimal/diagnóstico por imagen , Complicaciones Neoplásicas del Embarazo , Tumor Rabdoide/diagnóstico , Proteína SMARCB1/deficiencia , Adulto , Biomarcadores de Tumor/metabolismo , Terapia Combinada , Femenino , Humanos , Inmunohistoquímica , Recién Nacido , Enfermedades del Aparato Lagrimal/metabolismo , Enfermedades del Aparato Lagrimal/terapia , Embarazo , Tumor Rabdoide/metabolismo , Tumor Rabdoide/terapia , Tomografía Computarizada por Rayos XRESUMEN
Heterozygous mutations in the gene encoding fibroblast growth factor 10 (FGF10) or its cognate receptor, FGF-receptor 2 IIIb result in two human syndromes - LADD (lacrimo-auriculo-dento-digital) and ALSG (aplasia of lacrimal and salivary glands). To date, the partial loss-of-FGF10 function in these patients has been attributed solely to perturbed paracrine signalling functions between FGF10-producing mesenchymal cells and FGF10-responsive epithelial cells. However, the functioning of a LADD-causing G138E FGF10 mutation, which falls outside its receptor interaction interface, has remained enigmatic. In the present study, we interrogated this mutation in the context of FGF10's protein sequence and three-dimensional structure, and followed the subcellular fate of tagged proteins containing this or other combinatorial FGF10 mutations, in vitro We report that FGF10 harbours two putative nuclear localization sequences (NLSs), termed NLS1 and NLS2, which individually or co-operatively promote nuclear translocation of FGF10. Furthermore, FGF10 localizes to a subset of dense fibrillar components of the nucleolus. G138E falls within NLS1 and abrogates FGF10's nuclear translocation whilst attenuating its progression along the secretory pathway. Our findings suggest that in addition to its paracrine roles, FGF10 may normally play intracrine role/s within FGF10-producing cells. Thus, G138E may disrupt both paracrine and intracrine function/s of FGF10 through attenuated secretion and nuclear translocation, respectively.
Asunto(s)
Anomalías Múltiples/metabolismo , Núcleo Celular/metabolismo , Factor 10 de Crecimiento de Fibroblastos/química , Factor 10 de Crecimiento de Fibroblastos/metabolismo , Pérdida Auditiva/metabolismo , Enfermedades del Aparato Lagrimal/metabolismo , Sindactilia/metabolismo , Anomalías Dentarias/metabolismo , Anomalías Múltiples/genética , Transporte Activo de Núcleo Celular/genética , Transporte Activo de Núcleo Celular/fisiología , Secuencia de Aminoácidos , Western Blotting , Proliferación Celular/genética , Proliferación Celular/fisiología , Factor 10 de Crecimiento de Fibroblastos/genética , Células HEK293 , Pérdida Auditiva/genética , Humanos , Inmunohistoquímica , Enfermedades del Aparato Lagrimal/genética , Datos de Secuencia Molecular , Mutación , Transporte de Proteínas/genética , Transporte de Proteínas/fisiología , Sindactilia/genética , Anomalías Dentarias/genéticaRESUMEN
A 65-year-old man was referred to our hospital for the treatment of a lesion on the medial lacrimal canthus of both eyes. He had a history of perinuclear anti-neutrophil cytoplasmic antibodies, i.e., pANCA-positive interstitial pneumonia. Orbital magnetic resonance imaging excluded space occupying lesions, and laboratory testing excluded thyroid-related diseases. The masses were excised, and histopathological examinations showed sebaceous gland hyperplasia and inflammatory changes around the gland. In addition, the specimen from the left eye showed a retention cyst possibly caused by an infection. It was also possible that the use of steroid was involved in the development of the lesions. A relationship between the ANCA and the lesions was not completely eliminated.
Asunto(s)
Anticuerpos Anticitoplasma de Neutrófilos/inmunología , Enfermedades del Aparato Lagrimal/diagnóstico , Enfermedades Pulmonares Intersticiales/diagnóstico , Anciano , Humanos , Inflamación/inmunología , Inflamación/metabolismo , Enfermedades del Aparato Lagrimal/inmunología , Enfermedades del Aparato Lagrimal/metabolismo , Enfermedades Pulmonares Intersticiales/inmunología , Enfermedades Pulmonares Intersticiales/metabolismo , Masculino , Glándulas Sebáceas/inmunología , Glándulas Sebáceas/metabolismoRESUMEN
Presented is a rare case of basaloid adenocarcinoma of the lacrimal sac. Low grade features of this malignancy permitted a conservative surgical approach to maximize functional and cosmetic outcomes. This is retrospective case description of a single 77-year-old-female patient who underwent a dacryocystorhinostomy with silicone tubes at an outside hospital for epiphora, but was referred to the Wills Eye Hospital Oculoplastics Department for a lacrimal sac biopsy showing low-grade carcinoma with basaloid features. She was treated with complete excision of the mass, common canaliculus and distal canaliculi, and the nasolacrimal duct. The associated maxillary, lacrimal, and ethmoidal bones were similarly excised. Frozen sections were sent of the surrounding periosteum, orbital fat, nasal and sinus mucosa, and soft tissues, and all were negative. Reconstruction of the lacrimal system was performed with silicone tube intubation and the defect was closed with large glabellar and mid-facial flaps. One year post-operatively she maintained a normal ocular examination, and her eyelids and silicone tubes were well positioned. Systemic evaluation remained unrevealing. Basaloid adenocarcinoma of the lacrimal sac is relatively rare, and we highlight the role of a more conservative surgical intervention given the high rates of survival and low incidence of progression to metastatic disease when treating this rare malignancy.
Asunto(s)
Adenocarcinoma/patología , Neoplasias del Ojo/patología , Enfermedades del Aparato Lagrimal/patología , Adenocarcinoma/metabolismo , Adenocarcinoma/cirugía , Anciano , Biomarcadores de Tumor/metabolismo , Biopsia , Terapia Combinada , Dacriocistorrinostomía , Neoplasias del Ojo/metabolismo , Neoplasias del Ojo/cirugía , Proteínas del Ojo/metabolismo , Femenino , Humanos , Intubación , Enfermedades del Aparato Lagrimal/metabolismo , Enfermedades del Aparato Lagrimal/cirugía , Radioterapia , Estudios RetrospectivosAsunto(s)
Enfermedades de la Conjuntiva/complicaciones , Síndromes de Ojo Seco/etiología , Enfermedades del Aparato Lagrimal/etiología , Síndrome de Stevens-Johnson/complicaciones , Actinas/metabolismo , Adulto , Antígenos CD20/metabolismo , Biomarcadores/metabolismo , Síndromes de Ojo Seco/metabolismo , Síndromes de Ojo Seco/patología , Humanos , Enfermedades del Aparato Lagrimal/metabolismo , Enfermedades del Aparato Lagrimal/patología , Lactoferrina/metabolismo , Muramidasa/metabolismo , Estudios Prospectivos , Proteínas S100/metabolismoRESUMEN
A case of a pleomorphic adenoma of the lacrimal gland with a prominent clear cell myoepitheliomatous component was reported. An 81-year-old Caucasian woman experienced a 2-month history of right supraorbital swelling and proptosis. Excisional biopsy revealed a multicomponent lesion including a stromal component featuring glandular structures made of small epithelioid and spindle cells and a trabecular component with small islands of vacuolated cells, displaced nuclei, and clear cytoplasm. Immunohistochemical analysis revealed strong cytokeratin AE1/3 reactivity and focal smooth muscle actin positivity. The pathologic findings including immunohistochemistry results were consistent with a pleomorphic adenoma with prominent clear cell myoepithelioma component.
Asunto(s)
Adenoma Pleomórfico/patología , Neoplasias del Ojo/patología , Enfermedades del Aparato Lagrimal/patología , Mioepitelioma/patología , Adenoma Pleomórfico/metabolismo , Adenoma Pleomórfico/cirugía , Anciano de 80 o más Años , Biomarcadores de Tumor/metabolismo , Neoplasias del Ojo/metabolismo , Neoplasias del Ojo/cirugía , Femenino , Humanos , Enfermedades del Aparato Lagrimal/metabolismo , Enfermedades del Aparato Lagrimal/cirugía , Mioepitelioma/metabolismo , Mioepitelioma/cirugía , Proteínas de Neoplasias/metabolismoRESUMEN
Fourteen years after en bloc resection of an orbital pleomorphic adenoma, a 61-year-old female patient developed progressive left proptosis on the same side. A CT scan revealed a round, well-circumscribed, heterogeneously enhancing mass in the lacrimal fossa of the left orbit without calcification or bone erosion. An MRI scan showed a lesion that was hypointense on T1-weighted images and heterogeneously isointense on T2-weighted images. The tumor was completely resected through combined anterior and lateral orbitotomy. On histopathology, the specimen was identified as epithelial-myoepithelial carcinoma. After surgery, the patient received adjuvant therapy with irradiation of the orbit. At a 36-month follow-up evaluation, the patient remained tumor-free. Epithelial-myoepithelial carcinoma, a very uncommon tumor of the orbit, apparently behaves like a low-grade malignancy and is associated with good survival rates. However, a good prognosis for survival is tentative at best, in part because of the rarity of the lesion.
Asunto(s)
Adenoma Pleomórfico/patología , Células Epiteliales/patología , Neoplasias del Ojo/patología , Enfermedades del Aparato Lagrimal/patología , Mioepitelioma/patología , Neoplasias Primarias Secundarias , Actinas/metabolismo , Adenoma Pleomórfico/cirugía , Biomarcadores de Tumor/metabolismo , Células Epiteliales/metabolismo , Neoplasias del Ojo/metabolismo , Neoplasias del Ojo/cirugía , Femenino , Humanos , Inmunohistoquímica , Queratina-7/metabolismo , Enfermedades del Aparato Lagrimal/metabolismo , Enfermedades del Aparato Lagrimal/cirugía , Imagen por Resonancia Magnética , Proteínas de la Membrana/metabolismo , Persona de Mediana Edad , Mioepitelioma/metabolismo , Mioepitelioma/cirugía , Procedimientos Quirúrgicos Oftalmológicos , Tomografía Computarizada por Rayos XRESUMEN
INTRODUCTION: Necrotizing sialometaplasia is thought to represent an inflammatory reaction directed against an ischemic insult or local trauma within a glandular tissue and is most commonly observed in the minor salivary glands of the oral mucosa. The importance of this condition arises from the fact that its clinical and histological aspects may raise issues of differential diagnosis with malignant neoplasms. The authors present a case of necrotizing sialometaplasia involving the lacrimal sac simulating a well-differentiated squamous cell carcinoma. CASE: A 52-year-old man presented with epiphora in the left eye after having sustained an orbital blowout fracture during a motor vehicle accident. During subsequent external dacryocystorhinostomy, an abnormal lacrimal sac mucosa was observed and analyzed histologically revealing a well-differentiated squamous cell carcinoma. However, the subsequent biopsies of the lacrimal sac were negative for malignancy; in view of these findings, two pathologists reviewed the first specimen and immunohistochemical staining was performed allowing us to arrive at a diagnosis of necrotizing sialometaplasia. We suggest the term necrotizing dacryocystometaplasia for the involvement at this site. CONCLUSION: Although exceedingly unusual, necrotizing dacryocystomeplasia should be considered in patients presenting with epiphora in the appropriate clinical context. Notably, this condition can be mistaken for a malignant disease, presenting a diagnostic challenge both clinically and histopathologically.
Asunto(s)
Carcinoma de Células Escamosas/diagnóstico , Neoplasias del Ojo/diagnóstico , Enfermedades del Aparato Lagrimal/diagnóstico , Sialometaplasia Necrotizante/diagnóstico , Accidentes de Tránsito , Biomarcadores/metabolismo , Diagnóstico Diferencial , Huesos Faciales/lesiones , Humanos , Enfermedades del Aparato Lagrimal/metabolismo , Masculino , Persona de Mediana Edad , Fracturas Orbitales/etiología , Fracturas Orbitales/cirugía , Sialometaplasia Necrotizante/metabolismoRESUMEN
BACKGROUND: Lacrimal sac tumors are very rare and are often missed because patients present with features consistent with chronic dacryocystitis. Squamous cell carcinoma is the common-est lacrimal sac malignancy. Although primary mucoepidermoid carcinomas of the lacrimal sac are rare, they are locally aggressive. Furthermore, their proximity to vital structures and the skull base makes them potentially life-threatening. Multidisciplinary management is required, and wide excision followed by chemoradiation is the recommended treatment. CASE: Here, we report a 65-year-old male who presented with watering eyes and a mass in the region of the medial canthus. A dia-gnosis of primary mucoepidermoid carcinoma of the lacrimal sac was made, and the case was managed successfully with radical surgery and reconstruction. The tumor was resected using the extended Lynch-Howarth incision and the resulting defect was reconstructed using a forehead flap. Histopathological examination of the excised specimen revealed mucoepidermoid carcinoma. Immunohistochemical analysis revealed that the speci-men was positive for epithelial growth factor receptor and Ki-67 protein. The patient was referred for post-operative chemoradiation. The literature is reviewed and pathological features, including immunohistochemistry are discussed. CONCLUSION: Primary mucoepidermoid carcinoma of the lacrimal sac is a rare, locally aggressive tumor that is often mistaken for dacryocystitis. The treatment of choice is radical surgery followed by chemoradiation. KEY WORDS: lacrimal sac -â mucoepidermoid carcinoma -â epithelial growth factor receptor -â Ki-67 protein.
Asunto(s)
Carcinoma Mucoepidermoide/diagnóstico por imagen , Neoplasias del Ojo/diagnóstico por imagen , Enfermedades del Aparato Lagrimal/diagnóstico por imagen , Conducto Nasolagrimal/diagnóstico por imagen , Anciano , Carcinoma Mucoepidermoide/metabolismo , Carcinoma Mucoepidermoide/patología , Carcinoma Mucoepidermoide/cirugía , Receptores ErbB/metabolismo , Neoplasias del Ojo/metabolismo , Neoplasias del Ojo/patología , Neoplasias del Ojo/cirugía , Humanos , Inmunohistoquímica , Antígeno Ki-67/metabolismo , Enfermedades del Aparato Lagrimal/metabolismo , Enfermedades del Aparato Lagrimal/patología , Enfermedades del Aparato Lagrimal/cirugía , Masculino , Conducto Nasolagrimal/metabolismo , Conducto Nasolagrimal/patología , Conducto Nasolagrimal/cirugía , Tomografía Computarizada por Rayos XRESUMEN
Glial heterotopia is an extremely rare clinical entity mostly presenting in head and neck region secondary to an abnormal development of an isolated mature central nervous system (CNS) tissue at an abnormal location without any continuity with the brain, spinal cord, or meninges. Its origin is either due to mechanical isolation of glial tissues by the developing cranial bones or secondary to misdirected or sequestered embryonic neuroectodermal stem cells outside the CNS. The authors present an exceptionally rare case of a heterotopic glial nodule masquerading as a dacryocystocele, its radiological features along with a brief clinicopathological correlation.
Asunto(s)
Encéfalo , Coristoma/patología , Quistes/patología , Enfermedades del Aparato Lagrimal/patología , Neuroglía , Biomarcadores/metabolismo , Coristoma/diagnóstico por imagen , Coristoma/metabolismo , Coristoma/cirugía , Quistes/diagnóstico por imagen , Quistes/metabolismo , Quistes/cirugía , Diagnóstico Diferencial , Femenino , Proteína Ácida Fibrilar de la Glía/metabolismo , Humanos , Lactante , Enfermedades del Aparato Lagrimal/diagnóstico por imagen , Enfermedades del Aparato Lagrimal/metabolismo , Enfermedades del Aparato Lagrimal/cirugía , Tomografía Computarizada por Rayos X , Agudeza Visual/fisiologíaRESUMEN
Renal carcinoid tumor is an exceedingly rare malignancy. A 57-year-old man with a renal carcinoid tumor discovered after metastasizing to intraocular and bilateral orbital structures is described. The patient presented with a blind painful OS and a right superotemporal subconjunctival mass. Imaging studies revealed a large left intraocular tumor, a mass in the left medial rectus muscle, and right lacrimal gland enlargement. The OS was enucleated, and incisional biopsies were performed from the other 2 lesions. Histopathological studies demonstrated metastatic neuroendocrine tumor with chromogranin and synaptophysin positivity. Systemic work up revealed a right renal mass and multiple hepatic metastatic lesions. Radical nephrectomy was performed, and octreotide, capecitabine, and temozolomide were administered. Removal of the primary tumor and the eye that had no prospect for useful vision and further treatment with octreotide, capecitabine, and temozolomide provided a disease progression-free period of 24 months and allowed the patient to function normally.
Asunto(s)
Tumor Carcinoide/secundario , Neoplasias Renales/patología , Enfermedades del Aparato Lagrimal/patología , Neoplasias de los Músculos/secundario , Músculos Oculomotores/patología , Neoplasias de la Úvea/secundario , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Biomarcadores de Tumor/metabolismo , Capecitabina/administración & dosificación , Tumor Carcinoide/metabolismo , Tumor Carcinoide/terapia , Cromogranina A/metabolismo , Terapia Combinada , Dacarbazina/administración & dosificación , Dacarbazina/análogos & derivados , Enucleación del Ojo , Neoplasias del Ojo/metabolismo , Neoplasias del Ojo/secundario , Neoplasias del Ojo/terapia , Humanos , Neoplasias Renales/metabolismo , Neoplasias Renales/terapia , Enfermedades del Aparato Lagrimal/metabolismo , Enfermedades del Aparato Lagrimal/terapia , Masculino , Persona de Mediana Edad , Neoplasias de los Músculos/metabolismo , Neoplasias de los Músculos/terapia , Nefrectomía , Octreótido/administración & dosificación , Sinaptofisina/metabolismo , Temozolomida , Neoplasias de la Úvea/metabolismo , Neoplasias de la Úvea/terapiaRESUMEN
PURPOSE: To study genetic alterations in lacrimal gland pleomorphic adenoma (PA) and carcinoma ex pleomorphic adenoma (Ca-ex-PA) with focus on copy number changes and expression patterns of the translocation target genes PLAG1, HMGA2, and CRTC1-MAML2 in relation to clinical data. DESIGN: Experimental study. PARTICIPANTS: A total of 36 tumors from 32 patients with lacrimal gland PA or Ca-ex-PA were included in the study. METHODS: Genome wide, high-resolution array-based comparative genomic hybridization (arrayCGH) and immunohistochemistry were used to study the genomic profiles and expression patterns of the translocation targets PLAG1, HMGA2, and CRTC1-MAML2. MAIN OUTCOME MEASURES: Copy number alterations (gains/losses) and protein expression of PLAG1, HMGA2, and CRTC1-MAML2. RESULTS: Genome-wide arrayCGH analysis revealed normal genomic profiles in 10 of 17 PA samples. The average number of genomic imbalances per tumor was 3.25 (range, 1-7) in primary and recurrent PAs with alterations compared with 7.7 (range, 4-12) in Ca-ex-PAs. Five recurrent copy number alterations were identified in PAs, including losses of 1pter-p31.3, 6q22.1-q24.3, 8q24.22-q24.3, and 13q21.31-q21.33, and gain of 9p23-p22.3. Gain of 9p23-p22.3 also was seen in a Ca-ex-PA. In Ca-ex-PA, gain of 22q12.3-qter was the only recurrent alteration. Detailed analysis of the array data identified NFIB and PDGFB as the 2 major candidate target oncogenes that may be activated as a result of copy number gains involving 9p and 22q. Both genes have been implicated in the pathogenesis of PA and other types of salivary gland tumors. Immunohistochemical analysis revealed frequent overexpression of the translocation target gene PLAG1 in PAs and in 1 Ca-ex-PA. In contrast, overexpression of HMGA2 was observed in only a small subset of PAs. The CRTC1-MAML2 fusion oncoprotein was overexpressed in 2 mucoepidermoid Ca-ex-PAs. CONCLUSIONS: Lacrimal and salivary gland PAs and Ca-ex-PAs have similar genomic profiles and frequently overexpress the PLAG1 oncoprotein. Copy number gains involving 9p23-p22.3 (NFIB) and 22q12-qter (PDGFB) may be of importance for disease progression in a subset of lacrimal gland PAs.
Asunto(s)
Adenocarcinoma/genética , Adenoma Pleomórfico/genética , Neoplasias del Ojo/genética , Regulación Neoplásica de la Expresión Génica/genética , Fusión Génica , Enfermedades del Aparato Lagrimal/genética , Adenocarcinoma/metabolismo , Adenocarcinoma/patología , Adenoma Pleomórfico/metabolismo , Adenoma Pleomórfico/patología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Hibridación Genómica Comparativa , Variaciones en el Número de Copia de ADN , Proteínas de Unión al ADN/genética , Proteínas de Unión al ADN/metabolismo , Neoplasias del Ojo/metabolismo , Neoplasias del Ojo/patología , Femenino , Proteína HMGA2/genética , Proteína HMGA2/metabolismo , Humanos , Inmunohistoquímica , Enfermedades del Aparato Lagrimal/metabolismo , Enfermedades del Aparato Lagrimal/patología , Masculino , Persona de Mediana Edad , Proteínas Nucleares/genética , Proteínas Nucleares/metabolismo , Proteínas de Fusión Oncogénica , Transactivadores , Factores de Transcripción/genética , Factores de Transcripción/metabolismo , Translocación GenéticaRESUMEN
In this paper we have studied the thermal fluctuation patterns occurring at the ocular surface of the left and right eyes for aqueous deficient dry eye (ADDE) patients and control subjects by thermal imaging. We conducted our experiment on 42 patients (84 eyes) with aqueous deficient dry eyes and compared with 36 healthy volunteers (72 eyes) without any history of ocular surface disorder. Schirmer's test, Tear Break-up Time, tear Meniscus height and fluorescein staining tests were conducted. Ocular surface temperature measurement was done, using an FL-IR thermal camera and thermal fluctuation in left and right eyes was calculated and analyzed using MATLAB. The time series containing the sum of squares of the temperature fluctuation on the ocular surface were compared for aqueous deficient dry eye and control subjects. Significant statistical difference between the fluctuation patterns for control and ADDE was observed (p < 0.001 at 95% confidence interval). Thermal fluctuations in left and right eyes are significantly correlated in controls but not in ADDE subjects. The possible origin of such correlation in control and lack of correlation in the ADDE subjects is discussed in the text.
Asunto(s)
Temperatura Corporal/fisiología , Técnicas de Diagnóstico Oftalmológico , Síndromes de Ojo Seco/diagnóstico , Enfermedades del Aparato Lagrimal/diagnóstico , Lágrimas/metabolismo , Termografía/métodos , Adulto , Síndromes de Ojo Seco/metabolismo , Femenino , Humanos , Rayos Infrarrojos , Enfermedades del Aparato Lagrimal/metabolismo , MasculinoRESUMEN
PURPOSE: Evaluation of the tearing patient is often distilled to a search for ocular surface problems causing reflex hypersecretion versus lacrimal drainage problems. The literature does not typically emphasize conditions affecting the function of the tear distribution system, but neglect of these important factors can lead to suboptimal treatment outcomes. The intent of this review is to provide a systemic evaluation of frequently overlooked conditions that can influence the distribution system and to offer a mnemonic to ensure an orderly sequence of inspection during clinical examination. METHODS: Review of clinical literature and experience from 1957 to 2014. RESULTS: Tearing complaints attributable to problems with the distribution system can be evaluated, classified, and managed according to the mnemonic BLICK, which stands for Blink dynamics, Lid malposition, Imbrication, Conjunctivochalasis, and Kissing puncta. CONCLUSION: The BLICK mnemonic is a useful adjunct to the workup of epiphora.
Asunto(s)
Técnicas de Apoyo para la Decisión , Enfermedades del Aparato Lagrimal/diagnóstico , Lágrimas/metabolismo , Parpadeo/fisiología , Enfermedades de la Conjuntiva/metabolismo , Párpados/fisiología , Humanos , Enfermedades del Aparato Lagrimal/metabolismoRESUMEN
Intraductal carcinoma has been described in the salivary glands as a relatively benign tumour with low-grade histopathologic features. To our knowledge, this tumour has not previously been reported in the lacrimal gland. We report the first case of low-grade intraductal carcinoma occurring in the lacrimal gland. This tumour was discovered incidentally on neuro-imaging in an asymptomatic 65-year-old patient. Incisional biopsy revealed uniform, polygonal cells with eosinophilic cytoplasm and minimal nuclear atypia, arranged in solid, cribiform and micropapillary nests. The patient underwent complete surgical excision with no evidence of recurrence at 8 months of follow-up.